Volume 4, Issue 3 (Summer 2023)
J Vessel Circ 2023, 4(3): 117-122 |
Back to browse issues page
Ethics code: IR.MUQ.REC.1402.062
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Razavi M R, Mehrabi B, Akhavan Sepahi M, Aghaali M, Ghasemi S. Frequency of Renal Involvement and Its Characteristics in Patients With Henoch-Schönlein Purpura. J Vessel Circ 2023; 4 (3) :117-122
URL: http://jvessels.muq.ac.ir/article-1-265-en.html
URL: http://jvessels.muq.ac.ir/article-1-265-en.html
Mohammad Reza Razavi1 
, Bahareh Mehrabi * 1, Mohsen Akhavan Sepahi1 , Mohammad Aghaali2 , Shahima Ghasemi3
, Bahareh Mehrabi * 1, Mohsen Akhavan Sepahi1 , Mohammad Aghaali2 , Shahima Ghasemi3
1- Department of Pediatrics, School of Medicine, Hazrat-e Fateme Masoume Hospital, Qom University of Medical Sciences, Qom, Iran.
2- Department of Family and Community Medicine, Neuroscience Research Center, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Department of Pediatrics, Faculty of Medicine, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
2- Department of Family and Community Medicine, Neuroscience Research Center, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Department of Pediatrics, Faculty of Medicine, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
Abstract: (307 Views)
Background and Aim: This study investigated the frequency of renal involvement and its characteristics in patients with Henoch-Schönlein purpura who were referred to Hazrat Masoumeh Hospital in Qom City, Iran.
Materials and Methods: In this retrospective study, the files of 49 patients with Henoch-Schönlein purpura were reviewed. All clinical and paraclinical findings of the patients were reviewed, and the prevalence of renal complications in these patients was evaluated.
Results: In this study, 28 boys (57.1%) and 21 girls (42.9%) with an mean age of 53.7±35.3 months were examined. Three patients (6.1%) had underlying diseases, three patients (6.1%) had edema, 18 patients (36.7%) had arthritis, nine patients (18.4%) had petechiae, ten patients (20.4%) had abdominal pain, seven patients (14.3%) had leukocyturia, nine patients (18.4%) had microhematuria and hematuria, and three patients (6.1%) had proteinuria. The average creatinine and average blood urea levels were 0.6±0.1 and 25.4±11.1, respectively. Creatinine levels were elevated in 5 cases (10.2%) at the time of diagnosis and in 3 cases (6.1%) during the second week. Eight patients (16.3%) had kidney failure, and in three of these patients, there was an increase in proteinuria at the time of diagnosis. Additionally, three patients showed recovery, with improvement noted in two of these patients two weeks later and in one patient after the next six months. We observed disease recurrence in one patient (2%), nephrotic syndrome in one patient (2%), and proteinuria in two patients. In 33 cases (67.3%), no treatment was needed; ten cases were treated with non-steroidal anti-inflammatory drugs, three cases (6.1%) with Lasix, and the same number of cases were treated with corticosteroids. Also, among the patients who received treatment, one patient (3%) did not respond to the treatment.
Conclusion: Considering the kidney complications associated with this disease and the need for long-term follow-up for timely diagnosis, if any child is diagnosed with similar conditions, the follow-up of patients can help control and prevent these issues to a large extent.
Materials and Methods: In this retrospective study, the files of 49 patients with Henoch-Schönlein purpura were reviewed. All clinical and paraclinical findings of the patients were reviewed, and the prevalence of renal complications in these patients was evaluated.
Results: In this study, 28 boys (57.1%) and 21 girls (42.9%) with an mean age of 53.7±35.3 months were examined. Three patients (6.1%) had underlying diseases, three patients (6.1%) had edema, 18 patients (36.7%) had arthritis, nine patients (18.4%) had petechiae, ten patients (20.4%) had abdominal pain, seven patients (14.3%) had leukocyturia, nine patients (18.4%) had microhematuria and hematuria, and three patients (6.1%) had proteinuria. The average creatinine and average blood urea levels were 0.6±0.1 and 25.4±11.1, respectively. Creatinine levels were elevated in 5 cases (10.2%) at the time of diagnosis and in 3 cases (6.1%) during the second week. Eight patients (16.3%) had kidney failure, and in three of these patients, there was an increase in proteinuria at the time of diagnosis. Additionally, three patients showed recovery, with improvement noted in two of these patients two weeks later and in one patient after the next six months. We observed disease recurrence in one patient (2%), nephrotic syndrome in one patient (2%), and proteinuria in two patients. In 33 cases (67.3%), no treatment was needed; ten cases were treated with non-steroidal anti-inflammatory drugs, three cases (6.1%) with Lasix, and the same number of cases were treated with corticosteroids. Also, among the patients who received treatment, one patient (3%) did not respond to the treatment.
Conclusion: Considering the kidney complications associated with this disease and the need for long-term follow-up for timely diagnosis, if any child is diagnosed with similar conditions, the follow-up of patients can help control and prevent these issues to a large extent.
Type of Study: Research |
Subject:
vascular nephrology
Received: 2023/10/17 | Accepted: 2024/03/16 | Published: 2024/02/29
Received: 2023/10/17 | Accepted: 2024/03/16 | Published: 2024/02/29
References
1. Saulsbury FT. Clinical update: Henoch-schönlein purpura. The Lancet. 2007; 369(9566):976-8. [DOI:10.1016/S0140-6736(07)60474-7] [PMID] [DOI:10.1016/S0140-6736(07)60474-7]
2. Razavi SMR, Azadegan M, Rezvan S, Noori E. A case report of kawasaki disease with manifestations of acute renal. J Vessel Circ. 2020; 1(2):17-20. [DOI:10.29252/jvesselcirc.1.2.17] [DOI:10.29252/jvesselcirc.1.2.17]
3. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein Purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol. 2002; 13(5):1271-8. [DOI:10.1097/01.ASN.0000013883.99976.22] [PMID] [DOI:10.1097/01.ASN.0000013883.99976.22]
4. Chen O, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schonlein Purpura in children: Clinical analysis of 120 cases. Afr Health Sci. 2013; 13(1):94-9. [DOI:10.4314/ahs.v13i1.26] [DOI:10.4314/ahs.v13i1.26]
5. Dolezalová P, Telekesová P, Nemcová D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol. 2004; 31(11):2295-9. [PMID]
6. Yang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch-Schönlein purpura: An updated review. Autoimmun Rev. 2014; 13(4-5):355-8. [DOI:10.1016/j.autrev.2014.01.031] [PMID] [DOI:10.1016/j.autrev.2014.01.031]
7. Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schönlein purpura nephritis in childhood: Pathogenesis, prognostic factors, and treatment. Fukushima J Med Sci. 2013; 59(1):15-26. [DOI:10.5387/fms.59.15] [PMID] [DOI:10.5387/fms.59.15]
8. Sileikiene R, Tamakauskiene E, Baksiene D. [Henoch-Schönlein purpura - one of the most common types of systemic vasculitis in childhood (Lithuanian)]. Medicina (Kaunas). 2003; 39(5):476-9. [PMID]
9. Calvo-Río V, Loricera J, Mata C, Martín L, Ortiz-Sanjuán F, Alvarez L, et al. Henoch-Schönlein purpura in northern Spain: Clinical spectrum of the disease in 417 patients from a single center. Medicine. 2014; 93(2):106-113. [DOI:10.1097/MD.0000000000000019] [PMID] [DOI:10.1097/MD.0000000000000019]
10. Moradinejad MH, Ziaee V, Marashi SM, Nasri Nasrabadi Z. [Survey of clinical manifestations in Henoch Schönlein purpura in follow up (Persian)]. Med J Mashhad Univ Med Sci. 2014; 57(7):829-34. [DOI:10.22038/mjms.2014.3606]
11. Heidarian F, Saraf M, Hashemzadeh A. [Clinical and laboratory findings in henoch-schoenlein purpura (Persian)]. Iran J Pediatr. 2006; 16(2):227-9. [Link]
12. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr. 2002; 161(4):196-201. [DOI:10.1007/s00431-002-0922-z] [PMID] [DOI:10.1007/s00431-002-0922-z]
13. Schinzel V, Fernandez JD, Clemente G, Fraga MM, Andrade MC, Len CA, et al. The profile and clinical outcomes of patients with renal involvement due to IgA vasculitis: Is azathioprine a good option for treatment? Adv Rheumatol. 2019; 59(1):21. [PMID] [DOI:10.1186/s42358-019-0064-x]
14. Kim WK, Kim CJ, Yang EM. Risk factors for renal involvement in Henoch-Schönlein purpura. J Pediatr (Rio J). 2021; 97(6):646-50. [DOI:10.1016/j.jped.2021.01.008] [PMID] [DOI:10.1016/j.jped.2021.01.008]
15. Hahn D, Hodson EM, Willis NS, Craig JC. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP). Cochrane Database Syst Rev. 2015; 2015(8):Cd005128. [DOI:10.1002/14651858.CD005128.pub3] [DOI:10.1002/14651858.CD005128.pub3]
16. Mortazavi F, Sadeghi Shabestari M. [Clinical features and long term outcome of henoch-schonlein purpura in children admitted to children's hospital of Tabriz From 2001-2007 (Persian)]. Med J Tabriz Univ Med Sci. 2011; 33(3):68-73. [Link]
17. Assar S, Ahmadzadeh A, Ashornia P. Study on epidemiological, clinical and laboratory characteristics of children with Henoch-Schoenlein Purpura. Jundishapur Sci Med J. 2011; 10(3 (72)):262-9. [Link]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2717-0357
Email: jvessels[at]muq.ac.ir
j.vessels.circul[at]gmail.com
